LYV vs STRO · P/E 49, rev $23.16B vs rev $62.0M
Live Nation Entertainment Inc (LYV) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Live Nation Entertainment Inc (LYV) is a entertainment company listed on US.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported LYV revenue for 2024-12-31 was $23.16B. Net income was $1.13B. Revenue was up 1.9% from 2023-12-31 to 2024-12-31. LYV currently screens at market cap $33.36B and trailing P/E 48.8.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
LYV currently screens at market cap $33.36B and trailing P/E 48.8. STRO currently screens at market cap $470.8M.
Not investment advice. Open the LYV and STRO stock pages for the full models.
Not investment advice.